JP2014525417A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014525417A5 JP2014525417A5 JP2014527355A JP2014527355A JP2014525417A5 JP 2014525417 A5 JP2014525417 A5 JP 2014525417A5 JP 2014527355 A JP2014527355 A JP 2014527355A JP 2014527355 A JP2014527355 A JP 2014527355A JP 2014525417 A5 JP2014525417 A5 JP 2014525417A5
- Authority
- JP
- Japan
- Prior art keywords
- eluate
- concentration
- cation exchange
- exchange resin
- separately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161527974P | 2011-08-26 | 2011-08-26 | |
| US61/527,974 | 2011-08-26 | ||
| PCT/US2012/052567 WO2013033042A1 (en) | 2011-08-26 | 2012-08-27 | Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014525417A JP2014525417A (ja) | 2014-09-29 |
| JP2014525417A5 true JP2014525417A5 (enExample) | 2015-10-15 |
| JP6165143B2 JP6165143B2 (ja) | 2017-07-19 |
Family
ID=46970397
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014527355A Active JP6165143B2 (ja) | 2011-08-26 | 2012-08-27 | 血漿由来の免疫グロブリン組成物の血栓塞栓症の可能性を軽減する方法 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US9403899B2 (enExample) |
| EP (1) | EP2748193B1 (enExample) |
| JP (1) | JP6165143B2 (enExample) |
| KR (1) | KR101949553B1 (enExample) |
| CN (1) | CN103874708B (enExample) |
| AR (1) | AR087953A1 (enExample) |
| AU (1) | AU2012300220C1 (enExample) |
| BR (1) | BR112014004445B1 (enExample) |
| CA (1) | CA2846599A1 (enExample) |
| CL (1) | CL2014000480A1 (enExample) |
| CO (1) | CO6920256A2 (enExample) |
| EA (1) | EA030251B1 (enExample) |
| ES (1) | ES2624485T3 (enExample) |
| IL (1) | IL231083B (enExample) |
| MX (1) | MX349005B (enExample) |
| MY (1) | MY165164A (enExample) |
| SG (1) | SG11201400233TA (enExample) |
| TW (1) | TWI610937B (enExample) |
| WO (1) | WO2013033042A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2013203043B2 (en) * | 2013-03-15 | 2016-10-06 | Takeda Pharmaceutical Company Limited | Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs |
| ES2769783T3 (es) * | 2014-03-11 | 2020-06-29 | Green Cross Holdings Corp | Procedimiento de purificación de inmunoglobulina |
| US10287315B2 (en) | 2014-03-11 | 2019-05-14 | Green Cross Holdings Corporation | Method for purifying immunoglobulin |
| EP3275897A1 (en) * | 2016-07-27 | 2018-01-31 | Biotest AG | Process for preparing immunoglobulin compositions |
| KR101941974B1 (ko) * | 2016-11-18 | 2019-01-24 | 주식회사 녹십자 | 혈장 단백질 정제시 fxi의 제거방법 |
| IL270545B2 (en) * | 2017-06-12 | 2025-05-01 | Kamada Ltd | Immunoglobulin compositions and process for obtaining the same |
| JP2025514479A (ja) * | 2022-05-02 | 2025-05-02 | 武田薬品工業株式会社 | 血漿から限外濾過によりコーンプール濃縮物を調製する方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE348942B (enExample) | 1970-06-02 | 1972-09-18 | Statens Bakteriologiska Labor | |
| JPS5598117A (en) * | 1979-01-17 | 1980-07-25 | Chemo Sero Therapeut Res Inst | Purification of gamma-globulin derivative |
| US4639513A (en) | 1984-02-02 | 1987-01-27 | Cuno Inc. | Intravenously injectable immunoglobulin G (IGG) and method for producing same |
| DK166763C (da) | 1983-03-16 | 1993-07-12 | Immuno Ag | Immunoglobulin-g-holdig fraktion |
| US4482483A (en) | 1983-04-06 | 1984-11-13 | Armour Pharmceutical Company | Composition of intravenous immune globulin |
| EP0168506B2 (en) | 1984-07-07 | 1998-01-07 | Armour Pharma GmbH | Process for preparing gamma globulin suitable for intravenous administration |
| DE3640513A1 (de) | 1986-11-27 | 1988-06-09 | Biotest Pharma Gmbh | Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates |
| DE3641115A1 (de) | 1986-12-02 | 1988-06-16 | Lentia Gmbh | Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins |
| US5177194A (en) | 1990-02-01 | 1993-01-05 | Baxter International, Inc. | Process for purifying immune serum globulins |
| FR2706466B1 (fr) | 1993-06-14 | 1995-08-25 | Aetsrn | Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré. |
| ATE175979T1 (de) | 1993-12-27 | 1999-02-15 | Rotkreuzstiftung Zentrallab | Verfahren zur herstellung eines konzentrates von anti-d-immunoglobulin g und pharmazeutische zusammensetzung, die dieses enthält |
| GB9610992D0 (en) | 1996-05-24 | 1996-07-31 | Glaxo Group Ltd | Concentrated antibody preparation |
| US6162904A (en) | 1997-12-24 | 2000-12-19 | Alpha Therapeutic Corporation | Manufacturing method for intraveneously administrable immune globulin and resultant product |
| ES2421736T3 (es) * | 1998-06-09 | 2013-09-05 | Csl Behring Ag | Procedimiento para la preparación de inmunoglobulinas para administración intravenosa y otros productos inmunoglobulínicos |
| PL196770B1 (pl) * | 1998-06-09 | 2008-01-31 | Statens Seruminstitut | Sposób oczyszczania immunoglobuliny, produkt immunoglobuliny i jego zastosowanie |
| SE0001128D0 (sv) * | 2000-03-30 | 2000-03-30 | Amersham Pharm Biotech Ab | A method of producing IgG |
| BRPI1012082B1 (pt) * | 2009-05-27 | 2022-08-16 | Takeda Pharmaceutical Company Limited | Método para preparar uma composição de igg concentrada a partir de plasma |
| IL212911A0 (en) | 2011-05-16 | 2011-07-31 | Omrix Biopharmaceuticals Ltd | Immunoglobulin reduced in thrombogenic contaminants and preparation thereof |
-
2012
- 2012-08-27 SG SG11201400233TA patent/SG11201400233TA/en unknown
- 2012-08-27 ES ES12768938.8T patent/ES2624485T3/es active Active
- 2012-08-27 AR ARP120103162A patent/AR087953A1/es active IP Right Grant
- 2012-08-27 WO PCT/US2012/052567 patent/WO2013033042A1/en not_active Ceased
- 2012-08-27 TW TW101130949A patent/TWI610937B/zh active
- 2012-08-27 MY MYPI2014000533A patent/MY165164A/en unknown
- 2012-08-27 EA EA201400273A patent/EA030251B1/ru not_active IP Right Cessation
- 2012-08-27 AU AU2012300220A patent/AU2012300220C1/en active Active
- 2012-08-27 BR BR112014004445-7A patent/BR112014004445B1/pt active IP Right Grant
- 2012-08-27 CA CA2846599A patent/CA2846599A1/en not_active Abandoned
- 2012-08-27 JP JP2014527355A patent/JP6165143B2/ja active Active
- 2012-08-27 EP EP12768938.8A patent/EP2748193B1/en active Active
- 2012-08-27 CN CN201280050156.XA patent/CN103874708B/zh active Active
- 2012-08-27 KR KR1020147007936A patent/KR101949553B1/ko active Active
- 2012-08-27 MX MX2014002204A patent/MX349005B/es active IP Right Grant
- 2012-08-27 US US13/595,967 patent/US9403899B2/en active Active
-
2014
- 2014-02-23 IL IL231083A patent/IL231083B/en active IP Right Grant
- 2014-02-26 CL CL2014000480A patent/CL2014000480A1/es unknown
- 2014-03-20 CO CO14060700A patent/CO6920256A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014525417A5 (enExample) | ||
| KR101569783B1 (ko) | 항체의 정제 방법 | |
| JP2007532477A5 (enExample) | ||
| Vançan et al. | IMAC of human IgG: studies with IDA-immobilized copper, nickel, zinc, and cobalt ions and different buffer systems | |
| JP2011530592A5 (enExample) | ||
| RU2014111820A (ru) | Способы элиминации вируса | |
| JP2016519137A5 (enExample) | ||
| JP6592426B2 (ja) | 無塩条件下で疎水性相互作用クロマトグラフィーを使用するタンパク質精製 | |
| JP2013514073A5 (enExample) | ||
| JP2018087207A (ja) | 高純度の組換えヒト血清アルブミンを単離、精製するクロマトグラフ法 | |
| JP2016530533A5 (enExample) | ||
| Dai et al. | Comparison of activated carbon and ion-exchange resins in recovering copper from cyanide leach solutions | |
| TW201512217A (zh) | 單株抗體之新穎純化方法 | |
| Zhang et al. | A method for improving protein A chromatography's aggregate removal capability | |
| WO2015067147A1 (zh) | 重组蛋白质的纯化方法 | |
| GB2443505B (en) | Nucleic acid purification method | |
| Scheffel et al. | Highly selective Protein A resin allows for mild sodium chloride-mediated elution of antibodies | |
| JP2013511566A5 (enExample) | ||
| Bach et al. | Clearance of the rodent retrovirus, XMuLV, by protein A chromatography | |
| JP2012510500A5 (enExample) | ||
| BR112016027930B1 (pt) | recuperação de prata por meio de troca de íons | |
| CN103505908B (zh) | 一种利用混合模式层析介质连续分离纯化抗体的方法 | |
| CN115109142B (zh) | 一种从犬血浆中同时分离犬纤维蛋白原和犬凝血酶原复合物的方法 | |
| CN103694343B (zh) | 一种从尿液中制备人血白蛋白的方法 | |
| CN107405538B (zh) | 用于从来源于68Ge/68Ga发生器的洗脱物纯化Ga-68的工艺和用于所述工艺中的色谱柱 |